Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
33.7M
-
Shares change
-
-2.56M
-
Total reported value, excl. options
-
$284M
-
Value change
-
-$83.3M
-
Put/Call ratio
-
4.75
-
Number of buys
-
70
-
Number of sells
-
-44
-
Price
-
$8.43
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q4 2022
139 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q4 2022.
Pulmonx Corp - COMMON STOCK (LUNG) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.7M shares
of 40.4M outstanding shares and own 83.48% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (5.5M shares), Champlain Investment Partners, LLC (2.7M shares), BlackRock Inc. (2.69M shares), VANGUARD GROUP INC (2.42M shares), MORGAN STANLEY (2.15M shares), Point72 Asset Management, L.P. (1.76M shares), BRAIDWELL LP (1.62M shares), PFM Health Sciences, LP (1.46M shares), PURA VIDA INVESTMENTS, LLC (1.02M shares), and KPCB XIII Associates, LLC (995K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.